Endoscopic Ultrasound PANcreatic CAncer RaDIofrequeNcy AbLation

  • STATUS
    Recruiting
  • End date
    Jan 30, 2028
  • participants needed
    15
  • sponsor
    The University of Texas Health Science Center, Houston
Updated on 4 October 2021

Summary

The objectives of this study are to determine the feasibility, tolerability, and treatment effect of Endoscopic Ultrasound (EUS) Radiofrequency ablation (RFA) plus standard-of-care Neoadjuvant chemotherapy (NAC) in the treatment of Pancreatic Ductal Adenocarcinoma (PDAC).

Endoscopic Ultrasound (EUS) Radiofrequency ablation (RFA) and Neoadjuvant chemotherapy (NAC) will be performed before tumor resection surgery, with the goal of shrinking a tumor or stopping the spread of cancer so that surgery might be less invasive and more effective.

Details
Condition Pancreatic Ductal Adenocarcinoma
Treatment Endoscopic Ultrasound (EUS) Radiofrequency Ablation (RFA), Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA), Neoadjuvant chemotherapy (NAC)
Clinical Study IdentifierNCT04990609
SponsorThe University of Texas Health Science Center, Houston
Last Modified on4 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosed and histologically confirmed PDAC by biopsy
Permanent street address and consent to study participation
Axial CT scan consistent with PDAC
No prior chemotherapy or less than 2 months of pre-operative chemotherapy for PDAC
Eastern Cooperative Oncology Group (ECOG) performance status 0-2

Exclusion Criteria

No phone number of Male or Female patients > 18 years of age
Diagnosed and histologically confirmed PDAC by biopsy
No permanent street address or telephone number
Pregnant patients
Inmates or prisoners
Unable to provide informed consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note